Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni C Actis

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Minerva Gastroenterology|June 3, 2021
Telemedicine: historical roots, basic concepts, and today's useGiovanni C Actis
Inflammation & Allergy Drug Targets|June 24, 2014
The gut microbiomeGiovanni C Actis
Panminerva Medica|March 15, 2017
Helicobacter pylori 2017: revitalized therapies for an ever-challenging bugGiovanni C Actis
Minerva Gastroenterologica E Dietologica|February 13, 2019
Helicobacter pylori infection and Parkinson's diseaseGiovanni C Actis
Minerva Medica|June 18, 2016
The pathologic galaxy modulating the genotype and phenotype of inflammatory bowel disease: comorbidity, contiguity, and genetic and epigenetic factorsGiovanni C Actis, Rinaldo Pellicano
Minerva Gastroenterologica E Dietologica|February 18, 2016
Co-morbid immunopathological affections in outpatients with inflammatory bowel disease: a prospective studyGiovanni C Actis, Rinaldo Pellicano
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containmentGiovanni C Actis, Rinaldo Pellicano
Minerva Medica|November 9, 2017
Chronic (inflammatory) diseases: precision medicine versus comprehensive understanding?Giovanni C Actis, Rinaldo Pellicano
Nature Reviews. Gastroenterology & Hepatology|June 7, 2011
Ulcerative colitis: Rescue immune suppression for severe colitis--worth the risk?Giovanni C Actis, Marco Daperno
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 7, 2013
Inflammatory bowel disease: An archetype disorder of outer environment sensor systemsGiovanni C Actis, Floriano Rosina
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Minerva Gastroenterology|June 3, 2021
Telemedicine: historical roots, basic concepts, and today's useGiovanni C Actis
Inflammation & Allergy Drug Targets|June 24, 2014
The gut microbiomeGiovanni C Actis
Panminerva Medica|March 15, 2017
Helicobacter pylori 2017: revitalized therapies for an ever-challenging bugGiovanni C Actis
Minerva Gastroenterologica E Dietologica|February 13, 2019
Helicobacter pylori infection and Parkinson's diseaseGiovanni C Actis
Minerva Medica|June 18, 2016
The pathologic galaxy modulating the genotype and phenotype of inflammatory bowel disease: comorbidity, contiguity, and genetic and epigenetic factorsGiovanni C Actis, Rinaldo Pellicano
Minerva Gastroenterologica E Dietologica|February 18, 2016
Co-morbid immunopathological affections in outpatients with inflammatory bowel disease: a prospective studyGiovanni C Actis, Rinaldo Pellicano
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containmentGiovanni C Actis, Rinaldo Pellicano
Minerva Medica|November 9, 2017
Chronic (inflammatory) diseases: precision medicine versus comprehensive understanding?Giovanni C Actis, Rinaldo Pellicano
Nature Reviews. Gastroenterology & Hepatology|June 7, 2011
Ulcerative colitis: Rescue immune suppression for severe colitis--worth the risk?Giovanni C Actis, Marco Daperno
World Journal of Gastrointestinal Pharmacology and Therapeutics|August 7, 2013
Inflammatory bowel disease: An archetype disorder of outer environment sensor systemsGiovanni C Actis, Floriano Rosina
Pageof 4